Cargando…
Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice
Non-alcoholic fatty liver disease (NAFLD) is a major growing worldwide health problem. We previously reported that interruption of the enterohepatic circulation of bile acids using a non-absorbable apical sodium-dependent bile acid transporter inhibitor (ASBTi; SC-435) reduced the development of NAF...
Autores principales: | Rao, Anuradha, van de Peppel, Ivo P., Gumber, Sanjeev, Karpen, Saul J., Dawson, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052288/ https://www.ncbi.nlm.nih.gov/pubmed/32158763 http://dx.doi.org/10.3389/fmed.2020.00060 |
Ejemplares similares
-
The Beneficial Effects of Apical Sodium‐Dependent Bile Acid Transporter Inactivation Depend on Dietary Fat Composition
por: van de Peppel, Ivo P., et al.
Publicado: (2020) -
Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT
por: Hu, Nien-Jen, et al.
Publicado: (2011) -
Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury
por: Truong, Jennifer K., et al.
Publicado: (2022) -
Evolution of substrate specificity for the bile salt transporter ASBT (SLC10A2)
por: Lionarons, Daniël A., et al.
Publicado: (2012) -
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
por: Arab, Juan P., et al.
Publicado: (2016)